Table 1 Baseline characteristics of participants
Control | Study | |
|---|---|---|
Demographic and anthropometric variables | ||
N | 10 | 10 |
Age (yr) | 31.5 +/− 1.63 | 30.5 +/− 1.50 |
Body mass index (kg/m2) | 23.4 +/− 0.88 | 23.6 +/− 0.57 |
Stage of disease | ||
Stage I (minimal) | - | 0 (0) |
Stage II (mild) | - | 0 (0) |
Stage III (moderate) | - | 0 (0) |
Stage IV (severe) | - | 10 (100) |
Hormonal therapy | ||
Estrogen + progesterone | 6 (60) | 8 (80) |
Progesterone | 4 (40) | 2 (20) |
Indication for surgery | ||
Infertility + adnexal mass | - | 10 (100) |
Tubal ligation | 10 (100) | - |